Published in Hepatitis Weekly, October 31st, 2005
Study 1: HCV treatment causes changes in tear dynamics and changes on ocular surface.
"To evaluate symptoms and changes in tear function and the ocular surface with interferon and ribavirin therapy for chronic hepatitis C, nineteen patients with chronic hepatitis C underwent a course of interferon alfa-2b/ribavirin therapy. Nineteen age-and sex-matched controls participated in this prospective study," reported researchers from Taiwan in a recent issue of Cornea.
According to F.C. Huang and associates at the National Cheng Kung...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.